PHM16 PHARMACOKINETIC-PHARMACODYNAMIC-PHARMACOECONOMIC (P3) MODELING TO INFORM PHARMACOGENOMIC TRIAL DESIGN AND RISK MANAGEMENT

Nov 1, 2007, 00:00 AM
10.1016/S1098-3015(10)65043-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)65043-7/fulltext
Section Title :
Section Order : 203
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65043-7&doi=10.1016/S1098-3015(10)65043-7
HEOR Topics :
Tags :
Regions :